- Home
- ATCH vs INM Comparison
ATCH vs INM Comparison
Compare ATCH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- INM
- Stock Information
- Founded
- ATCH 2022
- INM 1981
- Country
- ATCH United States
- INM Canada
- Employees
- ATCH N/A
- INM N/A
- Industry
- ATCH
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ATCH
- INM Health Care
- Exchange
- ATCH Nasdaq
- INM Nasdaq
- Market Cap
- ATCH 3.2M
- INM 3.2M
- IPO Year
- ATCH N/A
- INM N/A
- Fundamental
- Price
- ATCH $0.20
- INM $2.78
- Analyst Decision
- ATCH
- INM
- Analyst Count
- ATCH 0
- INM 0
- Target Price
- ATCH N/A
- INM N/A
- AVG Volume (30 Days)
- ATCH 1.6M
- INM 5.8M
- Earning Date
- ATCH 08-27-2025
- INM 05-12-2025
- Dividend Yield
- ATCH N/A
- INM N/A
- EPS Growth
- ATCH N/A
- INM N/A
- EPS
- ATCH 2.67
- INM N/A
- Revenue
- ATCH N/A
- INM $4,920,990.00
- Revenue This Year
- ATCH N/A
- INM N/A
- Revenue Next Year
- ATCH N/A
- INM N/A
- P/E Ratio
- ATCH $0.08
- INM N/A
- Revenue Growth
- ATCH N/A
- INM N/A
- 52 Week Low
- ATCH $0.18
- INM $1.72
- 52 Week High
- ATCH $45.60
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ATCH 40.63
- INM 47.36
- Support Level
- ATCH $0.20
- INM $2.69
- Resistance Level
- ATCH $0.22
- INM $3.28
- Average True Range (ATR)
- ATCH 0.01
- INM 0.26
- MACD
- ATCH 0.01
- INM -0.03
- Stochastic Oscillator
- ATCH 47.03
- INM 8.79
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.